A novel device, TAD, has been developed to aid adherence to prescribed regimens and may have a roll in hospice pain management. This study aims to assess medication adherence relating to missed doses or improperly timed doses with and without the aid of a mobile device as a primary endpoint. Secondary endpoints will be patient, nursing, and provider satisfaction.
This study is a randomized crossover study in which patients will be randomized to start with or without a mobile device assisting the patient or caregiver in using the device. The investigators aim to enroll 20 patients across 3 sites. Each patient is expected to participate in the study for 12 weeks. After the first 2 weeks of participation, the patient will either begin using the mobile device to assist or will stop using the mobile device for the next 2 weeks. after the initial 4 weeks, the patient will choose to continue with or without using the mobile device.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
8
TAD is a device used to aid medication adherence.
Haven: Advanced Illness Care
Gainesville, Florida, United States
Haven: Advanced Illness Care
Lake City, Florida, United States
Haven: Advanced Illness Care
Palatka, Florida, United States
Difference from Scheduled Dosing Time
The time difference between when the patient took the dose and the scheduled time of administration.
Time frame: through study completion, up to 1 year
Missed Doses
The number of missed doses that occurred during the study.
Time frame: through study completion, up to 1 year
Patient Satisfaction: scale of 1 to 5
The patient's satisfaction will be measured on a scale of 1 to 5 (from 1 being extremely dissatisfied to 5 being extremely satisfied). Satisfaction will be assessed with the follow questions: 1. Using the mail order pharmacy to receive your pain medication? 2. Ease of using the TAD device to dispense your pain medication? 3. Ease of using the mobile device application with the TAD device? (ONLY when using the mobile application) 4. The ability of the device to provide you the dose of pain medication at the correct time? 5. The overall experience of using the TAD device?
Time frame: through study completion, up to 1 year
Nurse Satisfaction: scale of 1 to 5
The nurse's satisfaction will be measured on a scale of 1 to 5 (from 1 being extremely dissatisfied to 5 being extremely satisfied). Satisfaction will be assessed with the follow questions: 1. Using the mail order pharmacy get your patient their pain medication? 2. Your patient's ability to use the TAD device to dispense their pain medication? 3. Your patient's ability to use the mobile device application with the TAD device? (ONLY when using the mobile application) 4. The ability of the device to increase compliance of the pain medication? 5. The overall experience of using the TAD device?
Time frame: through study completion, up to 1 year
Physician Satisfaction: scale of 1 to 5
The physician's satisfaction will be measured on a scale of 1 to 5 (from 1 being extremely dissatisfied to 5 being extremely satisfied). Satisfaction will be assessed with the follow questions: 1. Using the mail order pharmacy get your patient their pain medication? 2. Your patient's ability to use the TAD device to dispense their pain medication? 3. Your patient's ability to use the mobile device application with the TAD device? (ONLY when using the mobile application) 4. The ability of the device to increase compliance of the pain medication? 5. The overall experience of using the TAD device?satisfaction will be measured on a scale of 1 to 5 for satisfaction of using the mail order pharmacy, ease of using the device, ease of using the mobile device, the ability of the device to accurately provide the dose, and overall experience with the device.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: through study completion, up to 1 year